Platelet-activating factor-acetylhydrolase fraction may be a useful new marker for coronary restenosis as well as vasospasm

被引：0
|
作者：
Okamura, K [1 ]
Miura, S [1 ]
Zhang, B [1 ]
Uehara, Y [1 ]
Nishikawa, H [1 ]
Shirai, K [1 ]
Matsuo, K [1 ]
Saku, K [1 ]
机构：
[1] Fukuoka Univ Hosp, Dept Cardiol, Fukuoka, Japan
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2005年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E97 / E97
页数：1
相关论文
共 50 条
  • [41] Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease
    Caslake, MJ
    Packard, CJ
    Suckling, KE
    Holmes, SD
    Chamberlain, P
    Macphee, CH
    ATHEROSCLEROSIS, 2000, 150 (02) : 413 - 419
  • [42] Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease
    Samsamshariat, Saedziaaldin
    Basati, Gholam
    Movahedian, Ahmad
    Pourfarzam, Morteza
    Sarrafzadegan, Nizal
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (05): : 674 - 679
  • [43] Lipoprotein Lipase and Hydrofluoric Acid Deactivate Both Bacterial Lipoproteins and Lipoteichoic Acids, but Platelet-Activating Factor-Acetylhydrolase Degrades Only Lipoteichoic Acids
    Seo, Ho Seong
    Nahm, Moon H.
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (08) : 1187 - 1195
  • [44] Single nucleotide polymorphisin (G994→T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass
    Unno, N
    Nakamura, T
    Mitsuoka, H
    Saito, T
    Miki, K
    Ishimaru, K
    Sugatani, J
    Miwa, M
    Nakamura, S
    SURGERY, 2002, 132 (01) : 66 - 71
  • [45] Reduced platelet-activating factor-acetylhydrolase activity in maternal plasma obtained from normotensive pregnant women destined develop pregnancy-induced hypertension
    Ohshige, A
    Yoshimura, T
    Matsui, K
    Koyama, H
    Ito, M
    Okamura, H
    HYPERTENSION IN PREGNANCY, 1998, 17 (03) : 297 - 306
  • [46] Red blood cells highly express type I platelet-activating factor-acetylhydrolase (PAF-AH) which consists of the α1/α2 complex
    Karasawa, K
    Shirakura, M
    Harada, A
    Satoh, N
    Yokoyama, K
    Setaka, M
    Inoue, K
    JOURNAL OF BIOCHEMISTRY, 2005, 138 (04): : 509 - 517
  • [47] Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect
    Milionis, HJ
    Tambaki, AP
    Kanioglou, CN
    Elisaf, MS
    Tselepis, AD
    Tsatsoulis, A
    THYROID, 2005, 15 (05) : 455 - 460
  • [48] Platelet-activating factor-acetylhydrolase G994T (exon 9) and A379V (exon 11) gene polymorphisms in relation to the onset of premature myocardial infarction in Taiwan
    Liu, P. -Y.
    Chen, J. -H.
    Li, Y. -H.
    Chao, T. -H.
    Lin, L. -J.
    Wu, H. -L.
    Liu, P. -Y.
    EUROPEAN HEART JOURNAL, 2005, 26 : 479 - 480
  • [49] Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice
    Quarck, R
    De Geest, B
    Stengel, D
    Mertens, A
    Lox, M
    Theilmeier, G
    Michiels, C
    Raes, M
    Bult, H
    Collen, D
    Van Veldhoven, P
    Ninio, E
    Holvoet, P
    CIRCULATION, 2001, 103 (20) : 2495 - 2500
  • [50] Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells
    Kell, PJ
    Creer, MH
    Crown, KN
    Wirsig, K
    McHowat, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03): : 1163 - 1170
12345